Globally 14,246,121 people have been infected with the virus while 601,549 people have died due to it according to Johns Hopkins University tracker.
A health official takes a swab sample from a man getting tested for the COVID-19 coronavirus through a window, at a testing point in Allahabad on July 17, 2020. - India on July 17 hit a million coronavirus cases, the third-highest total in the world, with no sign yet of the infection curve flattening as new cases emerge in rural areas. More than 25,000 people have died nationally. (Photo by SANJAY KANOJIA / AFP)
India’s coronavirus tally rose to 10,77,618 on Sunday which includes
3,73,379 active cases and 6,77,422 recovered cases according to data released by the ministry of health. The death toll due to the virus has climbed to 26,816.
Amidst surging infections, the AIIMS Ethics Committee on Saturday gave its nod for a human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin following which the premier hospital is likely to begin the exercise by enrolling healthy volunteers from Monday, reports PTI.
Advertisement
AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting phase I and II human trials of Covaxin. In phase I, the vaccine would be tested on 375 volunteers and a maximum of 100 of them would be from AIIMS.
Advertisement
Globally 14,246,121 people have been infected with the virus while 601,549 people have died due to it according to Johns Hopkins University tracker.
Advertisement
